Vanquish
NDC Package 59556-810-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vanquish is a . Marketed by Strides Pharma Inc, this product is identified by NDC 59556-810 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
59556-810-06
Package Description
1 BOTTLE in 1 CARTON / 100 TABLET, COATED in 1 BOTTLE
Product Code
59556-810
11-Digit Billing Format
59556081006

Clinical Specifications

Proprietary Name
Vanquish
Dosage Form
-

Regulatory & Marketing

Labeler Name
Strides Pharma Inc
FDA Application #
part343
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
06-26-2012
End Marketing Date
01-18-2022
Listing Expiration
01-18-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59556-810). Click a package code to view its specific billing and regulatory data.

59556-810-11
1 BOTTLE in 1 CARTON / 120 TABLET, COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59556-810-06 identifies a specific commercial package of 1 bottle in 1 carton / 100 tablet, coated in 1 bottle of Vanquish, labeled by Strides Pharma Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strides Pharma Inc on June 26, 2012. The current certification is valid through January 18, 2022.

How is this Strides Pharma Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59556081006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59556-810-06
11-Digit CMS (5-4-2)
59556-0810-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.